Imatinib-lnduced Agranulocytosis in a Patient With Chronic Myelogenous Leukemia in Remission

Isr Med Assoc J. 2008 Apr;10(4):320-1.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Agranulocytosis / chemically induced*
  • Agranulocytosis / physiopathology
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Piperazines / adverse effects*
  • Protein Kinase Inhibitors / adverse effects*
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate